Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Shyu

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Clinical Pharmacology and Therapeutics|May 1, 1991
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complexC A Knupp, W C Shyu, R Dolin, et al.
Pharmaceutical Research|July 1, 1997
Assessment of dose proportionality, absolute bioavailability, and immunogenicity response of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following subcutaneous and intravenous administration to ratsN R Srinivas, W C Shyu, R S Weiner, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
Excretion of cefprozil into human breast milkW C Shyu, V R Shah, D A Campbell, et al.
Diabetes, Obesity & Metabolism|December 1, 2010
Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjectsS Kasichayanula, X Liu, W C Shyu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 1998
Biotransformation of irbesartan in manT J Chando, D W Everett, A D Kahle, et al.
Journal of the Neurological Sciences|July 1, 1997
Application of chromosome 4q35-qter marker (pFR-1) for DNA rearrangement of facioscapulohumeral muscular dystrophy patients in TaiwanY D Hsu, M C Kao, W C Shyu, et al.
Journal of Pharmaceutical Sciences|March 1, 1996
Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: assessment using stereospecific and nonstereospecific assaysN R Srinivas, W H Barr, W C Shyu, et al.
Journal of Pharmaceutical Sciences|March 1, 1996
A pharmacokinetic study of intravenous CTLA4Ig, a novel immunosuppressive agent, in miceN R Srinivas, R S Weiner, W C Shyu, et al.
Journal of Pharmaceutical Sciences|January 1, 1996
Pharmacokinetics and pharmacodynamics of CTLA4lg (BMS-188667), a novel immunosuppressive agent, in monkeys following multiple dosesN R Srinivas, R S Weiner, G Warner, et al.
Journal of Neuroscience Research|May 11, 2005
Hypoglycemia enhances the expression of prion protein and heat-shock protein 70 in a mouse neuroblastoma cell lineW-C Shyu, C-P Chen, K Saeki, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|May 1, 1991
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complexC A Knupp, W C Shyu, R Dolin, et al.
Pharmaceutical Research|July 1, 1997
Assessment of dose proportionality, absolute bioavailability, and immunogenicity response of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following subcutaneous and intravenous administration to ratsN R Srinivas, W C Shyu, R S Weiner, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
Excretion of cefprozil into human breast milkW C Shyu, V R Shah, D A Campbell, et al.
Diabetes, Obesity & Metabolism|December 1, 2010
Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjectsS Kasichayanula, X Liu, W C Shyu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 1998
Biotransformation of irbesartan in manT J Chando, D W Everett, A D Kahle, et al.
Journal of the Neurological Sciences|July 1, 1997
Application of chromosome 4q35-qter marker (pFR-1) for DNA rearrangement of facioscapulohumeral muscular dystrophy patients in TaiwanY D Hsu, M C Kao, W C Shyu, et al.
Journal of Pharmaceutical Sciences|March 1, 1996
Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: assessment using stereospecific and nonstereospecific assaysN R Srinivas, W H Barr, W C Shyu, et al.
Journal of Pharmaceutical Sciences|March 1, 1996
A pharmacokinetic study of intravenous CTLA4Ig, a novel immunosuppressive agent, in miceN R Srinivas, R S Weiner, W C Shyu, et al.
Journal of Pharmaceutical Sciences|January 1, 1996
Pharmacokinetics and pharmacodynamics of CTLA4lg (BMS-188667), a novel immunosuppressive agent, in monkeys following multiple dosesN R Srinivas, R S Weiner, G Warner, et al.
Journal of Neuroscience Research|May 11, 2005
Hypoglycemia enhances the expression of prion protein and heat-shock protein 70 in a mouse neuroblastoma cell lineW-C Shyu, C-P Chen, K Saeki, et al.
Pageof 11